Related Experiment Video

Updated: Jun 12, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.7K

Exploring 'decision regret' in adjuvant-treated melanoma patients: Results from a cross-sectional survey on 200

T Grünke1, S Reiter1, S Meyer1

  • 1Department of Dermatology, Center for Dermato-Oncology, Eberhard Karls University of Tübingen, Tübingen, Germany.

Journal of the European Academy of Dermatology and Venereology : JEADV
|May 20, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

410

Related Experiment Videos

Last Updated: Jun 12, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.7K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

410

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Articles linked to this work by shared authors, journal, and citation graph.

Genomic correlates of metastatic competence and progression in human melanoma.

bioRxiv : the preprint server for biology·2026

Improvement of overall survival in patients with cutaneous melanoma at a tertiary care center in Germany from 2001 to 2020.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species.

Science (New York, N.Y.)·2026

Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

S1 guideline sweat gland carcinoma.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Cancers·2026

Experience-based recommendations for the diagnosis and management of early-stage nail unit melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Optimizing therapy in hidradenitis suppurativa: Combination, sequencing and treat-to-target.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

The future management of HS: People with HS as partners.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa: A nationwide cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma.

Frontiers in oncology·2026

Nanoprobe-Enabled Precision Imaging and Panoramic Boundary Delineation in Retinoblastoma.

Cancer innovation·2026

Number of examined lymph nodes and overall survival in intrahepatic cholangiocarcinoma: a population-based study suggesting a staging benefit.

Frontiers in oncology·2026

LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase.

Frontiers in pharmacology·2026

Lactate metabolism and lactylation in uveal melanoma: from metabolic adaptation to immune regulation.

Frontiers in immunology·2026

Associations between C-reactive protein-triglyceride glucose index and asthma risk among Chinese adults: evidence from the CHARLS cohort and external hospital-based validation.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us